NDC 55150-393

AZACITIDINE

Azacitidine

AZACITIDINE is a Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Eugia Us Llc. The primary component is Azacitidine.

Product ID55150-393_23509cbb-fa31-4369-98d1-2ce454828db9
NDC55150-393
Product TypeHuman Prescription Drug
Proprietary NameAZACITIDINE
Generic NameAzacitidine
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2023-01-03
Marketing CategoryANDA /
Application NumberANDA215066
Labeler NameEugia US LLC
Substance NameAZACITIDINE
Active Ingredient Strength100 mg/4mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 55150-393-01

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01) > 4 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2023-01-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "AZACITIDINE" or generic name "Azacitidine"

NDCBrand NameGeneric Name
0143-9606AzacitidineAzacitidine
0591-2897AzacitidineAzacitidine
0781-3253Azacitidineazacitidine
0781-9253Azacitidineazacitidine
16714-578AzacitidineAzacitidine
16714-777AzacitidineAzacitidine
16714-927AzacitidineAzacitidine
16729-306AzacitidineAzacitidine
43598-143AzacitidineAzacitidine
43598-305AzacitidineAzacitidine
43598-465AzacitidineAzacitidine
43598-678AZACITIDINEAZACITIDINE
43817-906AzacitidineAzacitidine
51991-797AzacitidineAzacitidine
55150-393AZACITIDINEAZACITIDINE
68001-313AzacitidineAzacitidine
69097-368AzacitidineAzacitidine
72485-201AZACITIDINEAZACITIDINE
63323-771AzacitidineAzacitidine
63759-0003AZACITIDINEAZACITIDINE
64679-096AZACITIDINEAZACITIDINE
67457-254AzacitidineAzacitidine
72606-558AZACITIDINEAZACITIDINE
71288-115AzacitidineAzacitidine
59572-730ONUREGazacitidine
59572-740ONUREGazacitidine
59572-102VIDAZAazacitidine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.